Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 19NIH 2NETWORK 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Wilms Tumor 3Prostatic Neoplasms 2Desmoid Tumors 2Colorectal Neoplasms 2Stage I Mixed Cell Type Kidney Wilms Tumor 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1Rhabdomyosarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Osteosarcoma 1Neurofibrosarcoma 1Neuroblastoma 1Mouth Neoplasms 1Melanoma 1Lymphoma, Non-Hodgkin 1Liposarcoma 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Leiomyosarcoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Histiocytoma, Malignant Fibrous 1

Interventions

bicalutamide 23Radiotherapy 21Goserelin 21Docetaxel 19Flutamide 17Leuprolide 16Prednisone 11Radiotherapy, Conformal 10Gonadotropin-Releasing Hormone 10Radiotherapy, Intensity-Modulated 9Triptorelin Pamoate 8Buserelin 8Estramustine 7Androgen Antagonists 7Brachytherapy 6luprolide acetate gel depot 5enzalutamide 5Paclitaxel 5nilutamide 4darolutamide 4acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 4Radiation 4Mitoxantrone 4Carboplatin 4orteronel 3apalutamide 3Selenium 3Orchiectomy 3Magnetic Resonance Spectroscopy 3Iodine-125 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Prostatic Neoplasms × X-Rays × Clear all
NCT05806515 2026-01-29

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

SWOG Cancer Research Network

Phase 2 Recruiting
44 enrolled
Genitourinary

Prostatic Neoplasms

NCT06470243 2026-01-22

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

SWOG Cancer Research Network

Phase 3 Recruiting
528 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡